PREVALENCE OF MUTATIONS IN THE GENES OF M. TUBERCULOSIS CODING THE DRUG RESISTANCE TO ISONIAZID AND RIFAMPYCIN AMONG URBAN AND RURAL POPULATIONS OF SARATOV REGION
Abstract
261 tuberculosis patients mainly su|ering from the pulmonary forms were enrolled into the comparative study of the pattern and prevalence of mutations in the genes of katG, inhA, ahpC and rpoB M. tuberculosis among urban and rural population. The testing was conducted with use of biological microchips and the set of reagents TB-Biochip, Russia. It has been found out that among tuberculosis patients constantly living in urban settings the multiple drug resistance is registered confidently more often compared to rural citizens – 38.6% against 23.2% respectively and the unfavorable pattern of mutations is detected in the genes of katG and rpoB, simultaneous multiple and concurrent mutations in 2-3 genes prevail. This requires development of additional measures of control over transmission of drug resistant strains of M. tuberculosis among urban population.
About the Authors
T. Yu. Salina
V. I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
T. I. Morozova
Saratov Regional Clinical TB Dispensary;
V. I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
A. N. Danilov
V. I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
References
1. Korovyakin V.S. Molecular basis of drug resistance of tuberculous mycobacteria. Med. Novosti. 2003, no. 9, pp. 8-13. (In Russ.)
2. Nechaeva O.B. Monitoring and evaluation of changes in tuberculosis epidemiological rates in the Russian Federation. Tub., 2012, no. 8, pp. 15-22. (In Russ.)
3. Stepanshin Yu.G., Stepanshina V.N., Shemyakin I.G. Molecular mechanisms of drug resistance of Mycobacterium tuberculosis. Antibiot. i Khimioterap., 1999, no. 4, pp. 39-43. (In Russ.)
4. Abubakar I., Zignol M., Falzon D. et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect. Dis., 2013, vol. 13, issue 6, pp. 529-539.
5. Acosta C.D., Dadu A., Ramsay A., Dara M. Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward. Intern. Union Against Tuberculosis and Lung Disease, 2014, vol. 4, suppl. 2, pp. 3-12.
6. Heym B., Alzari P.M., Honore N. Missense mutations in the catalase- peroxidase gene, katG, are associaciated with isoniasid resistance in Mycobacterium tuberculosis. Mol. Microbiolog., 1995, vol. 15, pp. 235-245.
7. Luo T., Zhao M., Li X. et al. Selection of Mutations to detect multidrug- resistant mycobacterium tuberculosis Strains in Shaghai, China. Antimicrob. Agents Chemother., 2010, vol. 54, no. 3, pp. 1075-1081.
8. Telenti A., Imboden P., Marchesi F. et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 1993, vol. 341, pp. 647-650.
9. Vareldzis B.P., Grosset J., de Kantor I. et al. Drug-resistant tuberculosis laboratory issues. World Health Organization recommendations. Tubercle Lung Dis., 1994, vol. 75, pp. 1-7.
10. Zhang Y., Yew W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis., 2009, vol. 13, pp. 1320-1330.
Review
For citations:
Salina T.Yu., Morozova T.I., Danilov A.N. PREVALENCE OF MUTATIONS IN THE GENES OF M. TUBERCULOSIS CODING THE DRUG RESISTANCE TO ISONIAZID AND RIFAMPYCIN AMONG URBAN AND RURAL POPULATIONS OF SARATOV REGION. Tuberculosis and Lung Diseases. 2015;(10):31-35. (In Russ.)
Views:
535
Email this article 